(AKTX) Akari Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Akari Therapeutics | (AKTX) share price targets
Complete technical analysis of Akari Therapeutics (AKTX) by charts plus indicators, forecast predictions and share price targets for Akari Therapeutics (AKTX)
Akari Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-07-03 View latest technical analysis
10 day averaged volume of Akari Therapeutics is 29760
| Date | Daily Closing Price | Open | High | Low | Volume |
| 03 Wed Jul 2024 | 3.18 | 3.23 | 3.31 | 3.10 | 0.077 times |
| 03 Wed Jul 2024 | 3.18 | 3.23 | 3.31 | 3.10 | 0.077 times |
| 02 Tue Jul 2024 | 3.10 | 3.27 | 3.40 | 3.04 | 0.796 times |
| 01 Mon Jul 2024 | 3.22 | 2.85 | 3.63 | 2.85 | 0.884 times |
| 28 Fri Jun 2024 | 2.70 | 2.70 | 2.70 | 2.61 | 0.413 times |
| 27 Thu Jun 2024 | 2.63 | 2.66 | 3.11 | 2.62 | 0.601 times |
| 26 Wed Jun 2024 | 2.72 | 2.89 | 3.11 | 2.71 | 0.682 times |
| 25 Tue Jun 2024 | 2.77 | 3.60 | 3.64 | 2.73 | 2.382 times |
| 24 Mon Jun 2024 | 3.66 | 3.80 | 3.89 | 3.49 | 0.78 times |
| 21 Fri Jun 2024 | 3.71 | 3.05 | 3.94 | 3.05 | 2.251 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 3.3 as stoploss in an intra day sell trade for a target of 3. However, stock will show a bullish move above 3.3.
Share price targets for Akari Therapeutics (AKTX)
| Target Type | Value |
| Downside Target | 1.08 |
| Downside Target | 1.17 |
| Downside Target | 1.62 |
| Downside Target | 1.66 |
| Downside Target | 1.85 |
| Downside Target | 2.35 |
| Downside Target | 2.44 |
| Downside Target | 2.61 |
| Downside Target | 2.70 |
| Downside Target | 2.85 |
| Downside Target | 3.07 |
| Upside Target | 3.31 |
| Upside Target | 3.63 |
| Upside Target | 3.89 |
| Upside Target | 3.94 |
Intraday share price targets for Akari Therapeutics (AKTX)
| Target Type | Value |
| Downside Intraday Target | 3.08 |
| Downside Intraday Target | 2.99 |
| Upside Intraday Target | 3.29 |
| Upside Intraday Target | 3.41 |
| Upside Intraday Target | 3.2 |
Weekly technical analysis of Akari Therapeutics (AKTX)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 03 Wed Jul 2024 | 3.18 | 3.23 | 3.31 | 3.10 | 0.044 times |
| 03 Wed Jul 2024 | 3.18 | 2.85 | 3.63 | 2.85 | 0.362 times |
| 28 Fri Jun 2024 | 2.70 | 3.80 | 3.89 | 2.61 | 1.275 times |
| 21 Fri Jun 2024 | 3.71 | 2.88 | 3.94 | 2.75 | 2.856 times |
| 18 Tue Jun 2024 | 2.84 | 3.05 | 3.07 | 2.70 | 0.173 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Akari Therapeutics (AKTX)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 03 Wed Jul 2024 | 3.18 | 2.85 | 3.63 | 2.85 | 0.078 times |
| 28 Fri Jun 2024 | 2.70 | 1.80 | 3.94 | 1.62 | 1.358 times |
| 31 Fri May 2024 | 1.71 | 1.54 | 2.35 | 1.17 | 1.272 times |
| 30 Tue Apr 2024 | 1.54 | 1.85 | 1.85 | 1.08 | 1.431 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Akari Therapeutics (AKTX)
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Akari Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Akari Therapeutics in short term but the sell signal is initial and weak.
Akari Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Akari Therapeutics in short term
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Akari Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.15 and Akari Therapeutics (AKTX) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Akari Therapeutics (AKTX) stock. Volume based technical analysis of Akari Therapeutics (AKTX) stock is negative.
Akari Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Akari Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Akari Therapeutics in short term but the sell signal is initial and weak.
Akari Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Akari Therapeutics in short term
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Akari Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.15 and Akari Therapeutics (AKTX) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Akari Therapeutics (AKTX) stock. Volume based technical analysis of Akari Therapeutics (AKTX) stock is negative.
Akari Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.